Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome

Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes?

(2011) V. G. Athyros et al.   CURRENT PHARMACEUTICAL DESIGN

Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women

(2011) Vassilios G. Athyros et al.   Current Vascular Pharmacology

Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia in Patients Using Lipid Lowering Drugs–The CEPHEUS-Greece Survey

(2010) Moses S. Elisaf et al.   ANGIOLOGY

Exercise and Weight Loss Improve Exercise Capacity Independent of Cardiac Function in Metabolic Syndrome

(2010) Anand Chockalingam et al.   ANGIOLOGY

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

(2010) Vasilios G. Athyros et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Effect of Antihypertensive Agents on Insulin Sensitivity, Lipids and Haemostasis

(2010) Asterios Karagiannis et al.   Current Vascular Pharmacology

Lipid-lowering agents and new onset diabetes mellitus

(2010) Vasilios G Athyros et al.   EXPERT OPINION ON PHARMACOTHERAPY

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

(2010) Vasilios G Athyros et al.   LANCET

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Blood Pressure Levels Constitute the Most Important Determinant of the Metabolic Syndrome in a Mediterranean Population: A Discrimination Analysis

(2010) Theodoros Chimonas et al.   Metabolic Syndrome and Related Disorders

Cardiovascular Risk Factors and Estimated 10-Year Risk of Fatal Cardiovascular Events Using Various Equations in Greeks With Metabolic Syndrome

(2009) Theodoros Chimonas et al.   ANGIOLOGY

Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study

(2009) V. G. Athyros et al.   CURRENT MEDICAL RESEARCH AND OPINION

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

Role of renin–angiotensin system in adipose tissue dysfunction

(2009) Masaru Iwai et al.   HYPERTENSION RESEARCH

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease

(2009) J. N. Basile   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

New Onset Diabetes During Antihypertensive Therapy

(2008) M. H. Alderman   AMERICAN JOURNAL OF HYPERTENSION

Coronary Collaterals in Obese Patients: Impact of Metabolic Syndrome

(2008) Hatice Sasmaz et al.   ANGIOLOGY

The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials

(2008) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE